The Centre for Bioengineering and Biotechnology is a catalyst for advancing bioengineering and biotechnology research and innovation through industry collaborations and partnerships.  

More than 150 faculty members, from every faculty on campus, are actively engaged with the centre, working in collaboration to provide a resource of varying expertise.

Our mandate is to build healthy, active partnerships between centre researchers and corporate members through collaborative projects, mutual interest building, and networking events.

To learn more about partnerships, please email us

  1. June 5, 2020New Executive Director of CBB Announcement: Congratulations Karim Karim!
    Karim S. Karim

    The Centre for Bioengineering and Biotechnology along and the University of Waterloo Office of Research are pleased to announce that Professor Karim S. Karim has accepted the role of Executive Director for a term of five years, ending March 31, 2025.

  2. Apr. 16, 2020CBB members Roderick Slavcev, Emmanuel Ho and Marc Aucoin team up to develop DNA-based COVID-19 vaccine
    COVID-19 molecules

    Researchers at the University of Waterloo are developing a DNA-based vaccine that can be delivered through a nasal spray.

    The vaccine will work by using bacteriophage, a process that will allow the vaccine to replicate within bacteria already in the body and is being designed to target tissues in the nasal cavity and lower respiratory tract.

  3. Mar. 28, 2020PPE for infectious disease preparedness featured in research paper from 2016 relevant for response to COVID-19

    The current COVID-19 pandemic has been putting a strain on healthcare workers around the world. We often forget all the challenges that frontline healthcare professionals have to face, including the use of personal protective equipment. This paper from 2016 describes the evaluation during the ebola crisis, which has excellent recommendations for healthcare workers and managers around the world when dealing with COVID-19.

Read all news
  1. Sep. 23, 2020Profs Present...The Tell-tale Sign of Antibodies: Determining COVID-19 Immunity with Blood Testing with Professor Brian Dixon
    Brian Dixon: The tell-tale sign of antibodies: Determining covid-19 immunity with blood testing

    COVID-19 has brought disease and mortality at levels not seen from a respiratory virus for over 100 years. Immune responses to this virus, which can infect several different tissues, are poorly understood, including the role of antibodies in resolving the infection. In March 2020, we reoriented our lab to develop Enzyme-Linked ImmunoSorbent Assays (ELISA) for human antibody isotypes IgM, IgG and IgA produced in response to the SARS-CoV-2 spike protein. To date we have analyzed samples from 114 patients, including both PCR positive and PCR negative individuals.

  2. Oct. 7, 2020Predicting Wellness with an Algorithm and Application by Rohan Shanbhag of Achu Health
    Predicting Wellness with an Algorithm and Application by Rohan Shanbhag of Achu Health

    Rohan Shanbhag will be discussing how Achu Health has developed an application based on a machine learning algorithm that uses data collected from a smartwatch to predict illness in individuals using the application.

All upcoming events